Aim: To investigate the features of skip lesions and evaluate value of top-hat procedure in management of squamous intraepithelial lesion. Methods: We reviewed the records of patients who underwent loop electrosurgical excision procedure (LEEP) in Peking University First Hospital between 2011 and 2016. Patients were confirmed to have CIN1-3. The term 'skip lesion' refers to lesion lying deep in cervical canal discontiguous with other lesions in transformation zone and was confirmed by top-hat. We compared their lesion grade in patients with or without skip lesion using logistic regression. We further reviewed patients who underwent subsequent hysterectomy within 6 months following LEEP and evaluated if top-hat procedure led to less residual lesions or was able to predict residual lesions. Results: A total of 2260 patients were included and 595 underwent top-hat procedure. Thirty-nine out of 595 patients had skip lesions (6.5%), among whom two patients had CIN1 (5.1%), eight had CIN2 (20.5%) and 29 had CIN3 (74.4%). Logistical regression showed CIN3 was associated with higher risk of skip lesions compared to CIN1 (OR = 4.433, 95%CI: 1.036-18.964), while CIN2 was not (OR = 1.762, 95%CI: 0.366-8.471). Sixty-two patients underwent hysterectomy within 6 months following LEEP (CIN1-3), 24 underwent top-hat. Analysis revealed top-hat procedure did not result in less residual lesions. Colposcopy impression or prior HPV test was unable to predict skip lesions. Conclusion: About 9.4% patients with CIN3 had skip lesions in the study, which is associated with elevated risk for residual lesion. Top-hat procedure is able to detect skip lesions, but should not be performed on routinely because its prognostic value is not proved.
Introduction
High grade intraepithelial lesions (HSIL) of the cervix are believed to be persistent precancerous lesions and should be removed in general circumstances. 1 Loop electrosurgical excision procedure (LEEP) is commonly performed to remove cervical squamous intraepithelial lesions (SIL) with desirable benefit-risk ratio, however, lesion persistence and recurrence after LEEP procedure present as a major problem yet to be issued. According to the literature, around 15% patients experience treatment failure. 2 Extensive efforts have been made in search for risk factors and most studies have found surgical margin involvement as the most predictive factor. 3 While it is widely believed that residual lesions are less likely to exist with a negative surgical margin, 4 we have detected SIL deeper in the endocervical canal even when the margin of first pass is clear. In other words, skip lesions may exist in patients with SIL, and may be left in cervical canal unnoticed after LEEP, leading to 'recurrence' of the lesion. It is well established that adenocarcinoma in situ (AIS) of the cervix tend to form multifocal lesions and strategies have been investigated to lower the hazard of 'recurrence' in patients with AIS. 5 However, the existence and importance of skip lesions in patients with SIL have been poorly studied. This study aims to describe the prevalence and features of skip lesions in patients with SIL and further investigate if top-hat procedure helps to detect and manage skip lesions, as the procedure may eliminate at least part of skip lesions.
Methods

Study population
The study was approved by the Institutional Ethical Review Board, Peking University First Hospital. We reviewed the records of patients who underwent LEEP procedure in Peking University First Hospital from January 2011 through December 2016. The inclusion criteria were CIN1-3 confirmed by histological examination of excised specimen. Patients to undergo LEEP were selected according to 2006 or 2012 consensus guidelines for the management of women with cervical intraepithelial neoplasia. 6, 7 Diagnostic excisions and excisions to treat persistent CIN1 were included in the study. LEEP performed to treat CIN2-3 and persistent CIN1 were defined as therapeutic excision. Patients with adenocarcinoma and squamous carcinoma were excluded. We then extracted patients who underwent two-step LEEP using top-hat procedure. Their age, degree of dysplasia (CIN1-3) and the existence of skip lesion were extracted for analysis.
To evaluate the prognostic value of top-hat procedure in patients with HSIL, we reviewed records of patients who underwent hysterectomy within 6 months following LEEP (including single or multiple pass) during the same period with initial diagnosis of CIN1-3 on LEEP specimen. Indications for hysterectomy include margin involvement or suspected endocervical lesions. Their age, degree of dysplasia on LEEP biopsy, whether top-hat or endocervical curettage (ECC) was performed, existence of residual lesions on hysterectomy and existence of skip lesions were extracted for analysis.
Data were de-identified and processed using a protected database.
Colposcopy
Colposcopy was performed by experienced colposcopists in our institute. Examinations were categorized as satisfactory or unsatisfactory depending on whether the squamocolumnar junction (SCJ) was fully visible. Acetowhitening test and iodine staining was performed and margin and vessels of the lesions were evaluated. Colposcopic impression was determined by Reid Colposcopic Index (lesions graded greater than 3 points would be reported as high grade). Guided biopsies were taken if the lesions were visible on colposcope, otherwise random biopsies at 3, 6, 9, 12 o'clock were sampled.
Loop electrosurgical excision procedure
The cervix was exposed using a speculum with associated smoke evacuation equipment. Lugol's iodine solution was used to outline lesion margins before the procedure. A local was induced by 1% lidocaine and epinephrine. A loop was selected according to the size of lesion and excision began from 3 to 5 mm outside the lateral perimeter of the lesion. Single pass or multiple pass excision was performed depending on the size and location of a lesion. As there was no recommended indication for endocervical evaluation, tophat procedure was performed based on judgment of colposcopist, for example, the procedure was more likely to be performed on patients with unsatisfactory colposcopy or had unmatched cytology and biopsy results. With this method, an initial pass was made to remove the ectocervical transformation zone, and a second smaller loop is passed more deeply into the cervical stroma to remove the endocervical canal, in a 'top-hat' style.
Pathologic examination
Excised specimens were fixed in 10% phosphatebufffered formalin and then transported to pathology laboratory. The specimens were opened along the cervical canal at 12 o'clock position and were pinned on a wax board with mucosa side up and external margin inked. Tissues were fixed overnight and cut along the axis of cervical canal into at least 12 blocks regarding clock positions. All tissue blocks were submitted for evaluation and each block was embedded in paraffin. At least three sections were obtained per paraffin block for hematoxylin and eosin staining. All the cases were reviewed by two experienced pathologists and classified as negative, CIN1-3, adenocarcinoma or squamous cell carcinoma according to World Health Organization criteria. P16 and Ki-67 immunohistochemical stains were performed occasionally for evaluation of equivocal cases. Marginal status was defined as positive if there was lesion on any grade on the margin, or negative if no lesion was observed on surgical margin. At least six sections were evaluated per block before negative margin was reported, if the block contained lesion. The highest degree of dysplasia detected was considered as a patient's lesion degree.
How we define 'skip lesion'
A lesion deeper in the cervical canal that is separated from the lesion touching the SCJ is defined as a skip lesion. In practice, if the specimen of the first pass contained SIL with a clear margin, while the top-hat specimen also contained SIL, then the patient was considered to have skip lesions.
Follow-up data
Follow-up records of patients with skip lesions were reviewed for evaluation of their outcome. Patients were recommended to take follow-up visits at 3-6 and 8-12 months after LEEP procedure and follow-up evaluation including thinprep cytology test (TCT). Abnormalities of TCT within the first year were considered to indicate cytological persistence. Those with abnormal results were referred for colposcopy and further treatment. Repetitive LEEP or hysterectomy was indicated by test results as well as patients' preference.
Statistical analysis
Statistical analysis was performed using SPSS software for windows (version 20.0; SPSS Inc.). Comparisons of odds ratios for skip lesions were analyzed using logistic regression analysis, and comparisons of continuous variables were analyzed with Student's t-test. P values (from two-sided tests) less than 0.05 were considered to indicate a significant difference.
Results
A total of 2260 patients met the criteria and 595 underwent top-hat procedure. Their baseline data were presented in Table 1 . Patients who underwent top-hat procedure were older than patient who took single pass (mean age 38.46 vs 41.71, P < 0.05), and had more severe lesions (linear by linear association method, P < 0.05).
Of the 595 patients who underwent top-hat procedure, 39 were found to have skip lesions (6.5%). Patients with and without skip lesions were comparable in age (mean age 42.1 vs 41.73, P = 0.844). Binary logistic regression revealed CIN3 as a risk factor for skip lesions compared CIN1 (OR = 4.433, 95%CI 1.036-18.964), while CIN2 was not (OR = 1.762, 95% CI 0.366-8.471). Notably, skip lesions were detected in 9.39% patients with CIN3 and underwent top-hat procedure (Table 2) .
To evaluate possible factors associated with skip lesions, we analyzed if transformation zone exposure, colposcopy impression, indication of LEEP, multiquadrant involvement and human papillomavirus (HPV) 16/18 infection were predictive for skip lesions. A total of 540 of the 595 patients underwent colposcopy at our institute and had eligible records for analysis. About 472 patients did HPV test. Chisquare test showed that none of the factors was associated with skip lesions (Table 3) . Notably, random biopsies detected much more high grade lesions than colposcopy. Colposcopy suggested high grade lesion in 327 of 540 patients, and colposcopy guided biopsies revealed HSIL in all of them. Biopsy revealed CIN2-3 in 469 patients and 142 of them were detected by random biopsies (data not shown in the tables).
As top-hat procedure was proved to be able to detect skip lesions and excise at least part of the lesion, we then tried to evaluate the prognostic value of top-hat procedure and compared top-hat procedure to ECC. Sixty-two patients underwent hysterectomy within 6 months following LEEP (including single or multiple pass) during the same period with initial diagnosis of CIN1-3 on LEEP specimen. The three patients with initial LEEP diagnosis of CIN1 underwent hysterectomy because of previous TCT and biopsy results suggest endocervical lesions and one of them had positive ECC result (CIN3). Results of pathological examination were presented in Table 4 . In our institute, we did not perform ECC following LEEP routinely and ECC was usually not performed if the patient underwent top-hat procedure.
To evaluate the prognostic value of top-hat procedure, we first examined whether top-hat procedure lowered the risk of residue lesion (of any grade) in hysterectomy specimen. Chi-square test showed tophat procedure did not lower the risk (χ 2 = 0.066, P = 0.797). To further evaluate whether top-hat procedure was able to predict residual lesions before hysterectomy, we extracted patients with CIN3 on LEEP specimen, as patients with CIN3 are high risk population for skip lesions for whom top-hat or ECC might be used for stratification. Cross tab was presented in Table 5 . Top-hat procedure was able to detect endocervical lesions with a sensitivity of 75% and a negative predictive value (NPV) of 71.4%, while specificity was 50% and positive predictive value (PPV) was 54.4%. The procedure was more reliable than ECC in detecting endocervical lesions, with the latter had sensitivity of 25% and specificity of 33%. However, chisquare test indicated that top-hat procedure was not able to predict residual lesions in patients with CIN3 (χ 2 = 1.169, P = 0.367, Fisher-exact test). Limited data might have weakened the value of the observation. Notably, skip lesions were detected in three patients (4.84%, all three patients had CIN3) and hysterectomy revealed residual lesions in all three patients (one had CIN3 and two had CIN2).
To further explore the association between skip lesions and risk for residual lesion, we extracted the follow-up record of the patients with skip lesions who did not undergo hysterectomy. Twenty-five had legible follow-up records of TCT tests (data not shown). Twelve of the 25 patients had abnormal results of either or both tests within 12 months after LEEP procedure, yielding a cytological persistence rate of 48%, which is much higher than what is reported by other studies. 8 Unfortunately we were unable to follow-up all patients who underwent LEEP during the period due to the retrospective nature of the study.
Discussion
It is well established that adenocarcinoma in situ have a higher incidence of multifocal or multicentric lesions. 5 Attempts have been made to investigate the clinical significance of the phenomenon and define treatment strategies. 9 However, studies concerning similar phenomenon in patients with squamous intraepithelial lesions have been limited, though many researchers have encountered such case and described the phenomenon in the literature that certain patients with clear surgical margins at conization had residual lesions in following ECC or hysterectomy specimen, [10] [11] [12] which implicate skip lesions. The retrospective study reviewed the record of patients who underwent top-hat procedure, which can detect skip lesions, and found 6.5% patients with SIL and 9.4% patients with CIN3 had skip lesions. Further analysis show CIN3 is a risk factor for skip lesions. The high prevalence of skip lesions in patients with CIN3 raised a question: is it appropriate to perform top-hat procedure on all patients diagnosed with CIN3? First we tested if top-hat was able to detect endocevical lesions. Top-hat was proved to be sensitive in detecting endocervical lesions and had acceptable NPV. However Chi-square analysis showed that results from top-hat specimen was not predictive for lesions in hysterectomy, so it might not be appropriate to use top-hat procedure routinely to triage patients with CIN3 to more radical treatment. The result is in accordance with recent research on endocervical sampling. 13 A possible explanation for the unsatisfying specificity and PPV of top-hat procedure might be its treatment value, as result from Kietpeerakool et al. suggested women with positive endocervical margins benefited from top-hat procedure, which lowered the risk for residual lesions compared to conventional procedure. 14 In the light of the hypothesis, we further evaluated if patients with CIN3 benefited from top-hat procedure regarding lesion persistence. The result, however, revealed that top-hat failed to improve the prognosis when the population is all patients with CIN3. The result is in accordance with observation from Cui and Kim 13, 15 but contradictory to the prospective study from Kietpeerakool et al.
14 The retrospective nature might have undermined our study and analysis of baseline status of patients who did or did not undergo top-hat procedure revealed significant difference between the two groups in terms of age and lesion grade, which are both associated with prognosis. There is still a lack of evidence to support the use of top-hat procedure in all patients with CIN3, especially when possible adverse events associated with increased excision volume is considered. 16 In the current study, at least five of 595 patients were hospitalized because of premature delivery or miscarriage as were recorded in our system. But we do not have further follow-up data for long term adverse events. Short term adverse events such as severe bleeding were not observed. However, we believe top-hat procedure may provide valuable information in certain subset of patients taking its acceptable sensitivity and NPV into consideration. Moreover, tophat procedure has proved its capability to detect skip lesions, which is associated with poor prognosis. The conclusion drawn by Cui et al. that top-hat provided limited prognostic information was partly based on the fact that they perform ECC routinely at colposcopy, 13 which is neither a routine at many institutions nor a recommendation. 17 Extensive studies have been done to identify possible risk factors for residual lesions after LEEP. Apart from the well acknowledged edocervical margin involvement, other proposed factors include multiquadrant involvement, menopausal status, 18 advanced age and type 3 transformation zone 10 and posttreatment HPV status. 19, 20 While HPV test can only be used for surveillance, the former ones can be assessed before LEEP and might assist the decision whether top-hat is to be performed. However, the current study found that neither colposcopy nor prior HPV test was predictive for skip lesions. Considering the small sample size and possible bias of the study, further studies on risk factors for skip lesions should be prompted to stratify patients who might benefit from the procedure. Meanwhile, the prognostic value of top-hat procedure warrant further prospective studies.
Notably, the LAST project recommended a twotiered classification (HSIL/LSIL) over the three-tiered classification (CIN1-3) of HPV-associated squamous lesions, as the former better reflect the biology of transient HPV infections and persistent precancerous lesions. The updated terminology aims to increase the reproducibility in histopathological interpretation but the two-tiered diagnosis may be further qualified with appropriate IN terminology. 1 With regard of the phenomenon described in the current study, an additional CIN classification may assist gynecologists to stratify patients at risk for skip lesions.
The primary drawback of the current study is its retrospective nature, thus we neither performed tophat procedure randomly nor followed subjective criteria for the procedure. In fact, significant difference was observed between patients who did or did not undergo the procedure and confounding factors undermined the reliability of our observation. We were also unable to collect follow-up data in all the patients. Lastly, the small sample size of hysterectomy confirmed residual lesion undermined the reliability of our analysis.
In conclusion, the primary finding of the study is the high prevalence of skip lesions in patients with CIN3, and that the kind of lesion is associated with high incidence of lesion persistence. Thus further studies on skip lesions in patients with SIL are needed to improve detection and proper management of the lesions. Secondly, the study do not support top-hat procedure as routine management in patients with CIN3, but further investigations should be carried on to stratify high risk subset that may benefit from the procedure and clarify proper indication of top-hat procedure.
